Categories
Change Password!
Reset Password!
Preemptive administration of targeted NSAIDs like etoricoxib, ibuprofen, and nimesulide effectively controls pain in single implants, while meloxicam and tenoxicam excel in complex surgeries.
Tackling postoperative pain, edema, and trismus remains a key clinical focus in implant dentistry. A novel systematic review issued in "The Journal of Oral Implantology" investigated the efficacy and safety of oral steroidal and nonsteroidal anti-inflammatory drugs (NSAIDs) administered as preemptive analgesia—prophylactically given before surgical intervention to mitigate pain pathways.
Analyzing 7 randomized controlled trials encompassing a total of 589 patients, the review evaluated a wide variety of drug agents, dosages, and combinations. Outcomes ascertained were postoperative pain, swelling (edema), restricted mouth opening (trismus), discomfort, and the need for rescue analgesics.
Key findings
Despite promising results, the review highlights notable limitations in current literature. Clinical heterogeneity—like varying drug regimens, diverse surgical scopes, and protocols that extended anti-inflammatory use into the postoperative phase—precluded a meta-analysis and made direct comparisons difficult. The authors emphasize that future trials must adopt rigorous methodological standardization and focus on widely utilized drug dosages to establish evidence-based guidelines for implant dentistry.
The Journal of Oral Implantology
Preemptive Analgesia With Steroidal and Nonsteroidal Anti-Inflammatory Drugs in Dental Implant Surgeries: A Systematic Review
Eduardo Gomes da Frota et al.
Comments (0)